In psychopathology, the p-factor suggests the presence of a common factor driving various mental health disorders. A recent Translational Psychiatry study aimed to discover p-factor-related plasma ...
Cerebrospinal fluid and plasma markers are now being used to help diagnose Alzheimer’s in memory clinics, but what about using them to stage the disease? That’s the next big step, said Henrik ...
Inflammation is known to contribute to Alzheimer’s disease progression, fueling the buildup of tau and amyloid pathology, and yet epidemiology suggests that people with the chronic inflammatory ...
Background: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to ...
pTau217, also called phosphorylated tau at threonine 217, is a specific blood-based biomarker for brain amyloid β pathology. When validated against CSF Aβ42/40 and PET imaging, the biomarker showed ...
Plasma protein biomarkers linked to urological cancer risk reveal causal targets and potential therapies through Mendelian ...
Plasma circulating tumor DNA (ctDNA) analysis is routine for genotyping of advanced non–small-cell lung cancer (NSCLC); however, early response assessment using plasma ctDNA has yet to be well ...
Type IV collagen 7s (ng/dl) 4.65 ± 0.93 5.94 ± 1.53 0.0018 Data are expressed as means ± SD. VFA = visceral fat area, SFA = subcutaneous fat area, AST = aspartate aminotransferase, ALT = alanine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results